FUB-PB-22

FUB-PB-22

FUB-PB-22
Systematic (IUPAC) name
quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate
Clinical data
Legal status
Identifiers
CAS Registry Number
Chemical data
Formula C25H17FN2O2
Molecular mass 396.41 g/mol

FUB-PB-22 is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2]

Legal status

FUB-PB-22 is a Anlage II controlled substance in Germany. It was scheduled in Japan in July 2014.

As of October 2015 FUB-PB-22 is a controlled substance in China.[3]

It is also banned in Sweden.[4]

See also

References

  1. ^ "FUB-PB-22". Southern Association of Forensic Scientists. Retrieved 23 July 2015. 
  2. ^ Nahoko Uchiyama, Yoshihiko Shimokawa, Ruri Kikura-Hanajiri, Yosuke Demizu, Yukihiro Goda, Takashi Hakamatsuka (February 2015). "A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products". Forensic Toxicology.  
  3. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015. 
  4. ^ "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015.